Xspray Pharma AB's total assets for Q1 2025 were kr737.71M, a decrease of -7.36% from the previous quarter. DE:6XP total liabilities were kr157.25M for the fiscal quarter, a -9.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.